CUTANEOUS SQUAMOUS CELL CANCER
Clinical trials for CUTANEOUS SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers? EVOLVE104 enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug called EVOLVE104 in 160 people with advanced bladder cancer or several types of squamous cell cancer that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
New drug combo trial aims to tame tough cancers
Disease control Recruiting nowThis early-stage trial tests a drug called sigvotatug vedotin, alone or with other medicines, in people with advanced solid tumors like lung, head and neck, or breast cancer. The goal is to find a safe dose and check for side effects. About 1,000 participants will join this study…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated May 26, 2026 07:22 UTC
-
Flu vaccine injected into skin cancer: could it rally immune cells?
Knowledge-focused Recruiting nowThis study is for people with a type of skin cancer called cutaneous squamous cell carcinoma who are waiting to have surgery to remove the tumor. Researchers want to see if injecting the seasonal flu vaccine directly into the tumor can attract more immune cells to fight the cance…
Matched conditions: CUTANEOUS SQUAMOUS CELL CANCER
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 07:22 UTC